Mid-Day Market Update: Nasdaq Jumps 300 Points; Aurora Cannabis Shares Plunge
U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Friday.
41 Stocks Moving In Friday’s Mid-Day Session
Gainers
Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares rose 60.2% to $1.7136. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.
Stifel Maintains Buy on Iovance Biotherapeutics, Lowers Price Target to $13
Stifel analyst Benjamin Burnett maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and lowers the price target from $26 to $13.
Oppenheimer Maintains Outperform on Iovance Biotherapeutics, Lowers Price Target to $27
Oppenheimer analyst Mark Breidenbach maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Outperform and lowers the price target from $31 to $27.
Piper Sandler Maintains Neutral on Iovance Biotherapeutics, Lowers Price Target to $13
Piper Sandler analyst Joseph Catanzaro maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Neutral and lowers the price target from $20 to $13.
4 Analysts Have This to Say About Iovance Biotherapeutics
Within the last quarter, Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings:
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
